1. Home
  2. VELO vs TNYA Comparison

VELO vs TNYA Comparison

Compare VELO & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Velo3D Inc.

VELO

Velo3D Inc.

HOLD

Current Price

$3.03

Market Cap

184.2M

Sector

Technology

ML Signal

HOLD

Logo Tenaya Therapeutics Inc.

TNYA

Tenaya Therapeutics Inc.

SELL

Current Price

$0.29

Market Cap

153.2M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
VELO
TNYA
Founded
2014
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
184.2M
153.2M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
VELO
TNYA
Price
$3.03
$0.29
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
6
Target Price
★ $19.50
$3.67
AVG Volume (30 Days)
1.6M
★ 2.5M
Earning Date
11-10-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 54.96
EPS
N/A
★ N/A
Revenue
★ $45,973,000.00
N/A
Revenue This Year
$61.07
N/A
Revenue Next Year
$28.07
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 12.12
N/A
52 Week Low
$3.16
$0.28
52 Week High
$31.75
$1.46

Technical Indicators

Market Signals
Indicator
VELO
TNYA
Relative Strength Index (RSI) 25.68 28.74
Support Level N/A N/A
Resistance Level $11.94 $0.42
Average True Range (ATR) 0.53 0.04
MACD -0.11 0.00
Stochastic Oscillator 0.57 11.92

Price Performance

Historical Comparison
VELO
TNYA

About VELO Velo3D Inc.

Velo3D Inc provides additive manufacturing (AM), also referred to as three-dimensional printing (3D printing), to deliver breakthroughs in performance, cost, and time in the production of high-value metal parts. The Velo3D intelligent metal additive manufacturing solution is comprised of the Velo3D Flow intelligent print preparation software, the Sapphire production system, and Velo3D Assure, real-time quality assurance software. Its complete manufacturing solution enables clients to build the parts needed, speed their development, and reduce their product costs.

About TNYA Tenaya Therapeutics Inc.

Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease.

Share on Social Networks: